CN Patent

CN107412212A — 经肺递送长效毒蕈碱拮抗剂及长效β2肾上腺素能受体激动剂的组合物及相关方法与系统

Assigned to Pearl Therapeutics Inc · Expires 2017-12-01 · 8y expired

What this patent protects

本申请提供了通过定量吸入器经肺递送长效毒蕈碱拮抗剂及长效B 2 肾上腺素能受体激动剂的组合物、方法及系统。在特定实施例中，组合物包含悬浮介质、活性剂颗粒、以及悬浮颗粒，其中活性剂颗粒与悬浮颗粒在悬浮介质中形成共悬浮液。

USPTO Abstract

本申请提供了通过定量吸入器经肺递送长效毒蕈碱拮抗剂及长效B 2 肾上腺素能受体激动剂的组合物、方法及系统。在特定实施例中，组合物包含悬浮介质、活性剂颗粒、以及悬浮颗粒，其中活性剂颗粒与悬浮颗粒在悬浮介质中形成共悬浮液。

Drugs covered by this patent

Patent Metadata

Patent number: CN107412212A
Jurisdiction: CN
Classification: —
Expires: 2017-12-01
Drug substance claim: No
Drug product claim: No
Assignee: Pearl Therapeutics Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.